Characterization of Acinetobacter baumannii carrying bla OXA-23, bla PER-1 and armA in a Korean hospital

Clinical Microbiology and Infection

Volumn 14, Issue 7, 2008, Pages 716-718

  Kim, J W ^a   Heo, S T ^b   Jin, J S ^a   Choi, C H ^a   Lee, Y C ^a   Jeong, Y G ^b   Kim, S J ^b   Lee, J C ^a  

^a Kyungpook National University School of Medicine   (South Korea)

^b Gyeongsang National University School of Medicine   (South Korea)

Author keywords

16S rRNA methylase; Carbapenemase; Extended spectrum b lactamase; Pandrug resistant; Sequence group

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; AZTREONAM; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE; BETA LACTAMASE OXA 23; BETA LACTAMASE PER 1; CARBAPENEM DERIVATIVE; CARBENICILLIN; CEFEPIME; CEFOPERAZONE; CEFOTAXIME; CEFTAZIDIME; CIPROFLOXACIN; COLISTIN; COTRIMOXAZOLE; GATIFLOXACIN; GENTAMICIN; IMIPENEM; MINOCYCLINE; NORFLOXACIN; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; PROTEIN ARMA; RNA METHYLTRANSFERASE; SULTAMICILLIN; TOBRAMYCIN; UNINDEXED DRUG;

ACINETOBACTER BAUMANNII; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL INFECTION; BACTERIAL STRAIN; BACTERIAL TRANSMISSION; BACTERIUM DETECTION; BACTERIUM ISOLATE; EPIDEMIC; GENE SEQUENCE; HETEROZYGOTE; HOSPITAL INFECTION; HUMAN; KOREA; MINIMUM INHIBITORY CONCENTRATION; MORBIDITY; MORTALITY; MULTIDRUG RESISTANCE; NONHUMAN; PRIORITY JOURNAL; SEPTIC SHOCK;

ACINETOBACTER BAUMANNII; ARMA;

EID: 45249112565     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2008.02022.x     Document Type: Article

References (20)

1. Falagas ME, Bliziotis IA, Kasiakou SK, Samonis G, Thanassopoulou P, Michalopoulos A. Outcome of infections due to pandrug-resistant (PDR) Gram-negative bacteria. BMC Infect Dis 2005; 5: 24-30.
2. Lee JH, Choi CH, Kang HY et al. Differences in phenotypic and genotypic traits against antimicrobial agents between Acinetobacter baumannii and Acinetobacter genomic species.13TU. J Antimicrob Chemother 2007; 59: 633-639.
3. Koeleman JG, Stoof J, Biesmans DJ, Savelkoul PH, Vandenbroucke-Grauls CM. Comparison of amplified ribosomal DNA restriction analysis, random amplified polymorphic DNA analysis, and amplified fragment length polymorphism fingerprinting for identification of Acinetobacter genomic species and typing of Acinetobacter baumannii. J Clin Microbiol 1998; 36: 2522-2529.
4. Clinical and Laboratory Standards Institute. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 17 edn. Wayne, PA: CLSI, 2007.
5. Lee K, Chong Y, Shin HB, Kim YA, Yong D, Yum JH. Modified Hodge and EDTA-disc synergy tests to screen metallo-β-lactamase-producing strains of Pseudomonas and Acinetobacter species. Clin Microbiol Infect 2001; 7: 88-91.
6. Jeon BC, Jeong SH, Bae IK et.al. Investigation of a nosocomial outbreak of imipenem-resistant Acinetobacter baumannii producing OXA-23 β-lactamase in Korea. J Clin Microbiol 2005; 43: 2241-2245.
7. Lee K, Yum JH, Yong D et al. Novel acquired metallo-β lactamase gene, bla SIM-1, in a class.1 integron from Acinetobacter baumannii clinical isolates from Korea. Antimicrob Agents Chemother 2005; 49: 4485-4491.
8. Afzal-Shah M, Woodford N, Livermore DM. Characterization of OXA-25, OXA-26, and OXA-27, molecular class.D β-lactamases associated with carbapenem resistance in clinical isolates of Acinetobacter baumannii. Antimicrob Agents Chemother 2001; 45: 583-588.
9. Vahaboglu H, Budak F, Kasap M et al. High prevalence of OXA-51-type class.D β.lactamases among ceftazidime-resistant clinical isolates of Acinetobacter spp.: Co-existence with OXA-58 in multiple centres. J Antimicrob Chemother 2006; 58: 537-542.
10. Turton JF, Ward ME, Woodford N et al. The role of IS Aba1 in expression of OXA carbapenemase genes in Acinetobacter baumannii. FEMS Microbiol Lett 2006; 258: 72-77.
11. Poirel L, Cavan L, Vahaboglu H, Nordmann P. Genetic environment and expression of the extended-spectrum β-lactamase bla PER-1 gene in gram-negative bacteria. Antimicrob Agents Chemother 2005; 49: 1708-1713.
12. Lee H, Yong D, Yum JH et al. Dissemination of 16S rRNA methylase-mediated highly amikacin-resistant isolates of Klebsiella pneumoniae and Acinetobacter baumannii in Korea. Diagn Microbiol Infect Dis 2006; 56: 305-312.
13. Yamane K, Wachino J, Doi Y, Kurokawa H, Arakawa Y. Global spread of multiple aminoglycoside resistance genes. Emerg Infect Dis 2005; 11: 951-953.
14. Yokoyama K, Doi Y, Yamane K et al. Acquisition of 16S rRNA methylase gene in Pseudomonas aeruginosa. Lancet 2003; 362: 1888-1893.
15. Yu YS, Zhou H, Yang Q, Chen YG, Li LJ. Widespread occurrence of aminoglycoside resistance due to ArmA methylase in imipenem-resistant Acinetobacter baumannii isolates in China. J Antimicrob Chemother 2007; 60: 454-455.
16. Seifert H, Dolzani L, Bressan R et al. Standardization and interlaboratory reproducibility assessment of pulsed-field gel electrophoresis-generated fingerprints of Acinetobacter baumannii. J Clin Microbiol 2005; 43: 4328-4335.
17. Turton JF, Gabriel SN, Valderrey C, Kaufmann ME, Pitt TL. Use of sequence-based typing and multiplex PCR to identify clonal lineage of outbreak strains of Acinetobacter baumannii. Clin Microbiol Infect 2007; 13: 807-815.
18. Falaga ME, Bliziotis IA. Pandrug-resistant Gram-negative bacteria: The dawn of the post-antibiotic era? Int J Antimicrob Agents 2007; 29: 630-636.
19. Doi Y, Adams JM, Yamane K, Paterson DL. Identification of 16S ribosomal RNA methylase-producing Acinetobacter baumannii clinical strains in North America. Antimicrob Agents Chemother 2007; 51: 4209-4210.
20. Henwood CJ, Gatward T, Warner M et al. Antibiotic resistance among clinical isolates of Acinetobacter in the UK, and in.vitro evaluation of tigecycline (GAR-936). J Antimicrob Chemother 2002; 49: 479-487.